Cargando…
Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity
There is an urgent need to identify which COVID-19 patients will develop life-threatening illness so that scarce medical resources can be optimally allocated and rapid treatment can be administered early in the disease course, when clinical management is most effective. To aid in the prognostic clas...
Autores principales: | Sindelar, Miriam, Stancliffe, Ethan, Schwaiger-Haber, Michaela, Anbukumar, Dhanalakshmi S., Albrecht, Randy A., Liu, Wen-Chun, Travis, Kayla Adkins, García-Sastre, Adolfo, Shriver, Leah P., Patti, Gary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872388/ https://www.ncbi.nlm.nih.gov/pubmed/33564793 http://dx.doi.org/10.1101/2021.02.05.21251173 |
Ejemplares similares
-
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity
por: Sindelar, Miriam, et al.
Publicado: (2021) -
Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem
por: Schwaiger-Haber, Michaela, et al.
Publicado: (2023) -
DecoID Improves Identification Rates in Metabolomics through Database-Assisted MS/MS Deconvolution
por: Stancliffe, Ethan, et al.
Publicado: (2021) -
A Workflow to Perform Targeted Metabolomics at the
Untargeted Scale on a Triple Quadrupole Mass Spectrometer
por: Schwaiger-Haber, Michaela, et al.
Publicado: (2021) -
A multidimensional metabolomics workflow to image biodistribution and evaluate pharmacodynamics in adult zebrafish
por: Jackstadt, Madelyn M., et al.
Publicado: (2022)